Amyris wins two grants for about $25 million

In California, Amyris announced two grants that have been awarded, valued in aggregate at approximately $25 million, to accelerate innovation and enable the company to further extend its leadership position in the industrial biotechnology sector. The first grant is in Europe and focused on furthering the company’s current artificial intelligence (AI) and Informatics platform at Amyris and the second grant is from National Institutes of Health (NIH) for the development of a novel isoprenoid pharmaceutical application.

These grants are expected to start funding within this quarter and continue for five years. Amyris will provide a detailed update for each of these grants once the final contracts are complete, which is expected to occur over the next 45 days.